open access
Telmisartan in the treatment of hypertension — optimal choice according to guidelines PTNT 2015
open access
Abstract
In recent years emphasis in the treatment of hypertension has been put on the individualization of treatment. The recently published guidelines of the Polish Society of Hypertension list several clinical situations in which use of angiotensin II receptor blockers (ARBs) is indicated. Blockade of the renin-angiotensin- aldosterone system plays a pivotal role in the treatment of high blood pressure and prevention of target organ damage. Telmisartan is an angiotensin II receptor blocker displaying beneficial unique pharmacologic properties, metabolic effects, antihypertensive efficacy in monotherapy and combinations and good tolerance. Clinical studies confirm that telmisartan improves endothelial function, insulin sensitivity and lipid profiles, reduces arterial stiffness. In addition, telmisartan improves renal function and has potential beneficial effects on prevention of cerebrovascular disease. The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET) study has shown that telmisartan provides similar cardiovascular protection to ramipril in high-risk patients, while being better tolerated.
Abstract
In recent years emphasis in the treatment of hypertension has been put on the individualization of treatment. The recently published guidelines of the Polish Society of Hypertension list several clinical situations in which use of angiotensin II receptor blockers (ARBs) is indicated. Blockade of the renin-angiotensin- aldosterone system plays a pivotal role in the treatment of high blood pressure and prevention of target organ damage. Telmisartan is an angiotensin II receptor blocker displaying beneficial unique pharmacologic properties, metabolic effects, antihypertensive efficacy in monotherapy and combinations and good tolerance. Clinical studies confirm that telmisartan improves endothelial function, insulin sensitivity and lipid profiles, reduces arterial stiffness. In addition, telmisartan improves renal function and has potential beneficial effects on prevention of cerebrovascular disease. The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET) study has shown that telmisartan provides similar cardiovascular protection to ramipril in high-risk patients, while being better tolerated.
Keywords
telmisartan, angiotensin II receptor blockers, hypertension, guidelines
Title
Telmisartan in the treatment of hypertension — optimal choice according to guidelines PTNT 2015
Journal
Issue
Article type
Editorial
Pages
145-151
Published online
2015-12-31
Page views
1140
Article views/downloads
4427
DOI
10.5603/AH.2015.0019
Bibliographic record
Arterial Hypertension 2015;19(4):145-151.
Keywords
telmisartan
angiotensin II receptor blockers
hypertension
guidelines
Authors
Krystyna Widecka